Data provide new perspective for understanding the antidepressant-like effects of a diabetes drug
Research in animals has shown that the diabetes drug dulaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist may reduce symptoms of depression. A new study published in Brain and Behavior reveals the mechanisms ...
Mar 6, 2024
0
1